42935-32-0

Basic information

• Product Name: LITHIUM 3,5-DIIODOSALICYLATE
• Synonyms: 2-HYDROXY-3,5-DIIODOBENZOIC ACID LITHIUM SALT;3,5-DIIODO-2-HYDROXYBENZOIC ACID LITHIUM SALT;3,5-DIIODOSALICYLATE LITHIUM SALT;3,5-DIIODOSALICYLIC ACID LITHIUM SALT;LIS;LITHIUM 2-HYDROXY-3,5-DIIODOBENZOIC ACID;LITHIUM 3,5-DIIODOSALICYLATE;LITHIUM 3,5-DIIODOSALICYLIC ACID
• CAS NO: 42935-32-0
• Molecular Formula: C7H3I2LiO3
• Molecular Weight: 395.85
• EINECS: 211-496-5
• Mol File: 42935-32-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: LITHIUM 3,5-DIIODOSALICYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: LITHIUM 3,5-DIIODOSALICYLATE(42935-32-0)
• EPA Substance Registry System: LITHIUM 3,5-DIIODOSALICYLATE(42935-32-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• F: 3-8-10
• Hazardous Substances Data: 42935-32-0(Hazardous Substances Data)

Usage

Description

LITHIUM 3,5-DIIODOSALICYLATE is a chemical compound derived from 3,5-diiodosalicylic acid, which is a metabolite of aspirin. It is characterized by the presence of two iodine atoms attached to the salicylate molecule. LITHIUM 3,5-DIIODOSALICYLATE has potential applications in various fields due to its unique chemical properties and interactions with biological systems.

Uses

Used in Pharmaceutical Industry:
LITHIUM 3,5-DIIODOSALICYLATE is used as a pharmaceutical agent for its agonist activity at GPR35, an orphan G protein-coupled receptor. This activity may contribute to the compound's potential therapeutic effects in various conditions, including inflammation and cancer prevention.
Used in Anti-inflammatory Applications:
LITHIUM 3,5-DIIODOSALICYLATE is used as an anti-inflammatory agent due to its metabolite origin from aspirin, which is a well-known anti-inflammatory, anti-platelet, and cancer-preventive agent. Its agonist activity at GPR35 may also contribute to its anti-inflammatory properties.
Used in Cancer Prevention:
LITHIUM 3,5-DIIODOSALICYLATE is used as a cancer-preventive agent, leveraging its metabolite origin from aspirin, which has been shown to have cancer-preventive properties. LITHIUM 3,5-DIIODOSALICYLATE's agonist activity at GPR35 may also play a role in its potential cancer-preventive effects.
Used in Drug Delivery Systems:
LITHIUM 3,5-DIIODOSALICYLATE can be used in drug delivery systems to improve the efficacy and targeted delivery of therapeutic agents. Its unique chemical properties and interactions with biological systems may enable the development of novel drug delivery approaches, enhancing the compound's therapeutic potential in various applications.